Sanguine Corporate Services Opc Profile
Key Indicators
- Authorised Capital ₹ 50.00 K
- Paid Up Capital ₹ 50.00 K
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 26.83%
- Profit Growth 52.02%
- Ebitda 43.53%
- Net Worth 25.82%
- Total Assets -31.68%
About Sanguine Corporate Services Opc
Sanguine Corporate Services Opc Private Limited (SCSOPL) is a Company incorporated in India on 18 February 2016 (Eight years and 11 months 29 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 K and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Kanwaljit Thanewal and Rohan Arora serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74110CH2016OPC035952
-
Company No.
035952
-
Incorporation Date
18 Feb 2016
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Sanguine Corporate Services Opc?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohan Arora
|
Director | 18-Feb-2016 | Current |
|
Kanwaljit Thanewal
|
Director | 20-Apr-2019 | Current |
Financial Performance of Sanguine Corporate Services Opc.
Sanguine Corporate Services Opc Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.83% increase. The company also saw a substantial improvement in profitability, with a 52.02% increase in profit. The company's net worth Soared by an impressive increase of 25.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Corporate Services Opc?
Unlock access to Sanguine Corporate Services Opc's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cheema Boilers LimitedKanwaljit Thanewal is a mutual person
-
Punjab Tissue LimitedKanwaljit Thanewal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanguine Corporate Services Opc?
Unlock and access historical data on people associated with Sanguine Corporate Services Opc, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Corporate Services Opc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Corporate Services Opc's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.